Suppr超能文献

多模态治疗或单纯手术治疗局限性食管癌患者生活质量的前瞻性评估

Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone.

作者信息

Reynolds J V, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne P J

机构信息

Department of Surgery, St James's Hospital and Trinity College Dublin, Dublin, Ireland.

出版信息

Br J Surg. 2006 Sep;93(9):1084-90. doi: 10.1002/bjs.5373.

Abstract

BACKGROUND

Health-related quality of life (HRQL) outcomes are important in assessing new approaches to the treatment of cancer. Neoadjuvant therapy is being used increasingly before surgery in patients with localized oesophageal cancer. This prospective non-randomized study evaluated HRQL in patients treated by preoperative chemotherapy and radiation therapy followed by surgery (multimodal therapy) or by surgery alone.

METHODS

Data from European Organization for Research and Treatment of Cancer quality of life questionnaires QLQ-30 and QLQ-OES24 were collected prospectively. Questionnaires were completed at diagnosis, after chemoradiotherapy where applicable, and at 3, 6 and 12 months after surgery.

RESULTS

The study included 202 consecutive patients with oesophageal cancer considered suitable for curative (R0) resection at the time of staging. Eighty-seven patients received chemotherapy combined with external-beam radiotherapy before surgery. At baseline, 75 (86 percent) of 87 patients in the multimodal group completed questionnaires, compared with 72 (62.6 percent) of 115 in the surgery-alone group. There were no significant differences in baseline global HRQL scores between groups. Preoperative chemoradiotherapy significantly reduced physical (P=0.004) and role (P=0.007) functioning before surgery, despite a significant (P=0.043) improvement in the dysphagia score. Oesophageal resection had a negative impact on global, functional and symptom HRQL scores at 3 months in both groups. Most variables had recovered by 6 months in the two groups, but at 12 months physical and role functioning remained impaired in the surgery-alone group, and social functioning and financial worries in the multimodal group.

CONCLUSION

Although the multimodal regimen had a negative impact on HRQL before surgery, postoperative quality of life in patients who had multimodal therapy was similar to that in those who had surgery alone.

摘要

背景

健康相关生活质量(HRQL)结果在评估癌症治疗新方法中很重要。新辅助治疗在局部食管癌患者手术前的应用日益增多。这项前瞻性非随机研究评估了接受术前化疗和放疗后手术(多模式治疗)或仅接受手术治疗的患者的HRQL。

方法

前瞻性收集来自欧洲癌症研究与治疗组织生活质量问卷QLQ - 30和QLQ - OES24的数据。问卷在诊断时、适用时在放化疗后以及手术后3、6和12个月完成。

结果

该研究纳入了202例连续的食管癌患者,这些患者在分期时被认为适合进行根治性(R0)切除。87例患者在手术前接受了化疗联合外照射放疗。基线时,多模式治疗组87例患者中的75例(86%)完成了问卷,而单纯手术组115例中的72例(62.6%)完成了问卷。两组之间基线总体HRQL评分无显著差异。术前放化疗在手术前显著降低了身体(P = 0.004)和角色(P = 0.007)功能,尽管吞咽困难评分有显著改善(P = 0.043)。食管切除对两组患者术后3个月的总体、功能和症状HRQL评分有负面影响。两组中大多数变量在6个月时恢复,但在12个月时,单纯手术组的身体和角色功能仍受损,多模式治疗组的社会功能和经济担忧仍存在。

结论

尽管多模式治疗方案在手术前对HRQL有负面影响,但接受多模式治疗的患者术后生活质量与单纯接受手术的患者相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验